This evidence- and case-based course examines combination therapy for slowing childhood myopia progression—low-dose atropine, orthokeratology, soft multifocal contact lenses, and spectacles. Through three cases, attendees learn to select, combine, monitor, and adjust individualized plans.
Speaker: Thanh Mai OD, FSLS
Date: Monday, September 21, 2026
Time: 5:30 PM - 6:30 PM Pacific Time
Location: Virtual
Moderator: Dr. Jennifer Stewart
Cost: Free!
COPE ID: 106415-GO
Category: General Optometry
This event is undergoing COPE approval for 1 hour CE credit.
Thank you to Euclid for exhibiting at this event.
Euclid Vision Corporation is a global leader in advanced orthokeratology and proactive myopia management. Euclid is the exclusive manufacturer of Euclid MAX™ Ortho-K lenses for overnight wear to reshape the cornea and wake up to clear vision. Today, Euclid is proven on millions of eyes around the world. The Euclid Ortho-K treatment has a unique, empirically fit lens design that yields an 87% first fit success.* No trial set is required. Newly introducing the Be Free® Day lens which is designed to make contact lens myopia care simple, effective, and clinically credible. Developed in partnership with the Brien Holden Vision Institute (BHVI), Be Free® Day lens combines proprietary myopia optics, premium comfort technology, and the breathability of silicone hydrogel material.